Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RET inhibitor for use in treating cancer having a RET alteration

RET inhibitor for use in treating cancer having a RET alteration

US Patent 11872192 · Granted Jan 16, 2024

Estimated economic value: $65,176,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RET inhibitor for use in treating cancer having a RET alteration2024
RET inhibitor for use in treating cancer having a RET alteration2024
RET inhibitor for use in treating cancer having a RET alteration2022
RET inhibitor for use in treating cancer having a RET alteration2022
Diagnostic assays and kits for detection of folate receptor 12020
Diagnostic assays and kits for detection of folate receptor 12019
Dosage and administration of anti-EGFR therapeutics2018
Diagnostic assays and kits for detection of folate receptor 12017
Dosage and administration of anti-EGFR therapeutics2017
Diagnostic assays and kits for detection of folate receptor 12015
Compositions and methods relating to STOP-12010
Fibroblast activation protein inhibitor compounds and methods2008